Cargando…

Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition

Osteonecrosis of the jaws (ONJ) in osteoporosis patients has been defined as rare, but the number of reported cases is increasing. We report a case of delayed ONJ diagnosis in a patient, who was being treated with alendronate, developing bone alterations both in maxilla and in mandible. Underestimat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Migliario, Mario, Mergoni, Giovanni, Vescovi, Paolo, De Martino, Iolanda, Alessio, Manuela, Benzi, Luca, Renò, Filippo, Fusco, Vittorio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806981/ https://www.ncbi.nlm.nih.gov/pubmed/29563419 http://dx.doi.org/10.3390/dj5010013

Ejemplares similares

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
por: Catania, Gioacchino, et al.
Publicado: (2016)

Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
por: Erovigni, Francesco, et al.
Publicado: (2016)

Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors
por: Wan, Jason T., et al.
Publicado: (2020)

Osteonecrosis of the jaw (ONJ) in patients who receive Bone Targeting Agents (BTAs): the power of e-learning
por: Nicolatou-Galitis, Ourania, et al.
Publicado: (2018)

Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates—Preliminary data(): Medical ozone gas insufflation in treating ONJ lesions
por: Ripamonti, C.I., et al.
Publicado: (2012)

Gradual, but Not Sudden, Dose-Dependent Increase of ONJ Risk With Bisphosphonate Exposure: A Nationwide Cohort Study in Women With Osteoporosis
por: Park, Jung-Hyun, et al.
Publicado: (2021)

Piezo-electric surgery use for the management of patients with onj drug-induced: our experience
por: Cristofaro, M G, et al.
Publicado: (2010)

Determination of the molecular mechanism by which macrophages and γδ-T cells contribute to ZOL-induced ONJ
por: Qu, Xingzhou, et al.
Publicado: (2020)

Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (S(s))-DS-ONJ
por: Gómez-Jaramillo, Laura, et al.
Publicado: (2022)

Case report of maxillofacial fracture in a patient under bisphosphonates in the absence of ONJ disease: Guidelines?
por: Van Camp, Philippe, et al.
Publicado: (2018)

Conservative Surgical Management of Stage I Bisphosphonate-Related Osteonecrosis of the Jaw
por: Vescovi, Paolo, et al.
Publicado: (2014)

Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ
por: Kaur, Kawaljit, et al.
Publicado: (2023)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors
por: Manfredi, Maddalena, et al.
Publicado: (2017)

Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw
por: Roato, Ilaria, et al.
Publicado: (2023)

Decreasing Frequency of Osteonecrosis of the Jaw in Cancer and Myeloma Patients Treated with Bisphosphonates: The Experience of the Oncology Network of Piedmont and Aosta Valley (North-Western Italy)
por: Fusco, Vittorio, et al.
Publicado: (2013)

Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients
por: Jung, Sung-mok, et al.
Publicado: (2018)

Osteonecrosis of the Jaw
por: Lončar Brzak, Božana, et al.
Publicado: (2023)

Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)
por: Bedogni, A, et al.
Publicado: (2012)

Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate
por: Figueiredo, Marília A., et al.
Publicado: (2020)

A multicenter observational study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in advanced cancer and myeloma patients of a cancer network in North-Western Italy
por: Fusco, Vittorio, et al.
Publicado: (2021)

Atypical Femoral Fracture Combined with Osteonecrosis of Jaw During Osteoporosis Treatment with Bisphosphonate
por: Won, Yougun, et al.
Publicado: (2014)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
por: Taguchi, Akira, et al.
Publicado: (2017)

Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis
por: Mustakim, Kezia Rachellea, et al.
Publicado: (2023)

Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019)

Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022)

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
por: Campisi, Giuseppina, et al.
Publicado: (2020)

Analysis of Factors Associated with the Postoperative Healing of Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis
por: Shim, Young-Ho, et al.
Publicado: (2021)

Osteonecrosis of the jaws in patients under osteoporosis treatment: a nine-year experience report
por: Penoni, Daniela Cia, et al.
Publicado: (2023)

Bisphophonates related osteonecrosis of the jaw
por: Gupta, Swati, et al.
Publicado: (2013)

Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients
por: Gammelager, Henrik, et al.
Publicado: (2013)

The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention
por: Di Fede, Olga, et al.
Publicado: (2018)

Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis
por: Aljohani, Suad
Publicado: (2023)

Osteonecrosis of jaw associated with bisphosphonate use
por: Rastogi, Ashu, et al.
Publicado: (2012)

Bisphosphonate-related osteonecrosis of the jaws (Bronj)
por: Beninati, Francesco, et al.
Publicado: (2013)

Osteonecrosis of the jaws in patients treated with bisphosphonates
por: Ata-Ali, Fadi, et al.
Publicado: (2012)

Bisphosphonate-Related Osteonecrosis of the Jaw: Specificities
por: Paulo, Siri, et al.
Publicado: (2014)

Expert opinion about osteonecrosis of the jaw
por: Lee, Jeong Keun
Publicado: (2017)

Outcomes of Clinical Trials on Osteonecrosis of the Jaw
por: Wu, Brendan W, et al.
Publicado: (2021)

Medication-related osteonecrosis of the jaw: An update
por: Bansal, Hitesh
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jd59f8i8hv5r1tg42td6qajmlg